Multiple myeloma with significant renal dysfunction: CrCl <60 mL/min or serum creatinine...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-MM-RENAL-DYSFUNCTION |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-MM |
| Sources | SRC-ESMO-MM-2023 SRC-NCCN-MM-2025 |
Red Flag Origin
| Definition | Multiple myeloma with significant renal dysfunction: CrCl <60 mL/min or serum creatinine >177 µmol/L (>2 mg/dL) attributable to myeloma kidney |
|---|---|
| Clinical direction | investigate |
| Category | organ-dysfunction |
Trigger Logic
{
"any_of": [
{
"comparator": "<",
"finding": "creatinine_clearance_ml_min",
"threshold": 60
},
{
"comparator": ">",
"finding": "serum_creatinine_mg_dl",
"threshold": 2.0
},
{
"finding": "mm_renal_failure",
"value": true
}
],
"type": "lab_result"
}
Notes
Direction "investigate" — triggers lenalidomide dose adjustment in BOTH VRd and D-VRd and demands further workup (24-hr urine, kidney biopsy in selected cases) to distinguish myeloma kidney from other causes. Does not shift the algorithm's regimen choice (proteasome inhibitors are renal-safe and remain effective at recovering renal function), but mandates dose modification surfaced as a particularity in the rendered Plan. The schema enum doesn't have "dose_adjust" — "investigate" is the closest match per §9.
Used By
Algorithms
ALGO-MM-1L- ALGO-MM-1L
Indications
IND-MM-2L-DKD- IND-MM-2L-DKDIND-MM-3L-ISA-KD- IND-MM-3L-ISA-KDIND-MM-ELDERLY-FRAIL-VRD-LIGHT- IND-MM-ELDERLY-FRAIL-VRD-LIGHT
Questionnaires
QUEST-MM-1L- Multiple Myeloma — newly diagnosed (1L)
Red flag
RF-ORGAN-RENAL-IMPAIRED- Renal impairment requiring dose modification: moderate (CrCl 30-50 mL/min) or severe (CrC...